Effects of Multiple Applications of Tumor Promoters and Ultraviolet Radiation on Epidermal Proliferation and Antioxidant Status  by Cameron, Gregory S. & Pence, Barbara C.
Effects of Multiple Applications of Tumor Promoters 
and Ultraviolet Radiation on Epidermal Proliferation 
and Antioxidant Status 
Gregory S. Cameron and Barbara C. Pence 
Departments of Dermatology/Cell Biology and Anatomy (GSC) and Pathology (BCP), Texas Tech University Health Sciences 
Center, Lubbock, Texas, U.S.A. 
The dorsal skin of hairless mice (Skh: HR-1) was treated 
with multiple applications of acetone, 12-0-tetradecanoyl-
phorbol-13-acetate (TPA) or ethyl phenylpr?piolate ~E~P) 
two times per week, or exposed to ultraviolet radiation 
(UVR) three times per week for treatment periods up to 16 
weeks. Epidermal hyperplasia, as measured by epidermal 
thickness, was increased in all three treatment groups after a 
single (0.5 weeks) TPA: EPP, or UVR treat~ent. TPA- and 
EPP-induced hyperplasia had begun to subside by 16 weeks, 
whereas UVR-induced hyperplasia was still increasing at that 
point. Epidermal homogenates were examined for ornithine 
decarboxylase (ODe) activity 6 h after the final treatment at 
0.5, 2, 8, and 16 weeks of treatment. ODC activity WaS 
elevated in all treatment groups (TPA > EPP > UVR), with 
UVR induction returning to near control (acetone) levels by 
E pidermal hyperplasia, the induction of ornithine decar-boxylase (ODe) activity and DNA synthesis, decreases in the levels of epidermal antioxidants, and the produc-tion of free radical compounds are events that occur in the early stages of tumor promotion and the early timing 
of these occurrences has been well documented [1- 6]. However, 
the process of tum~r promotion requires lengthy, regular treat-
ments with promotmg agents and the cellular responses dunng 
these extended exposures to tumor promoters are not as well docu-
mented. Previous studies have demonstrated that hyperplasia is in-
duced and antioxidant enzymes are diminished following single 
treatments of phorbol esters [4] and ultraviolet light [7,8]. Analysis 
of epidermal hyperplasia and the antioxidant status of skin exposed 
for extended periods to tumor promoters should provide infor11).a-
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Abbreviations: 
CAT: catalase 
EPP: ethyl phenylpropiolate 
ODC: ornithine decarboxylase 
SOD: superoxide dismutase 
TLC: thin-layer chromatography 
TPA: 12-0-tetradecanoylphorbol-13-acetate 
UVR: ultraviolet radiation 
XO: xanthine oxidase 
16 weeks even though the UVR-induced hyperplasia con-
tinued to increase at the 16-week point. Homogenates exam-
ined for superoxide dismutase (SOD), catalase (CAT), and 
xanthine oxidase (XO) activity 48 h after the final treatment 
at 0.5,2,4, 8, 12, and 16 weeks had decreased activities of 
both SOD and CAT. TPA and EPP elevated XO, but UVR 
had little or no effect. Our data indicate that promoter-in-
duced hyperplasia persists for extended periods of time and 
that diminution of antioxidant defenses observed following 
prolonged tumor-promoter treatment persists through .the 
time period when tumors would be expected to begin. This 
antioxidant diminution may be one of a cascade of events that 
leads to epidermal proliferation and tumor promotion in 
mouse skin.] Invest DermatoI99:189-192, 1992 
tion on the relative importance and significance of these factors and 
their occurrence early versus late in the tumor-promotion process. 
In order to examine this question we have exposed mouse skin to the 
tumor promoters 12-0-tetradecanoylphorbol-13-acetate (TP A), 
ethyl phenylpropiolate (EPP), or ultraviolet radiation (UVR) for 
periods up to 16 weeks and examined the epidermal response in 
terms of hyperplasia, as well as ODC, superoxide dismutase (SOD), 
catalase (CAT), and xanthine oxidase (XO) activity. 
MATERIALS AND METHODS 
Mice The mice used in this study were six-week-old female 
Skh: HR-1 hairless mice supplied by the Temple University breed-
ing facility . The mice were held for 1 week after receipt and then 
immediately utilized for the study. 
Treatment Scheme The mice were divided into four groups and 
each group treated with either acetone, TPA, EPP, or UVR. Ace-
tone (200 ,ul), 2,ug TPA (in 200,u1 acetone) (LC Services, Woburn, 
MA), or 5 mg EPP (in 200,u1 acetone) (Aldrich Chemical Co., Inc., 
Milwaukee, WI) were applied two (2) times per week. Mice ex-
posed to UVR were treated three (3) times per week with 0.09 
J/ cm2 ultraviolet light at wavelengths of290 - 320 nm (FS-40 Med-
ical Sunlamps, National Biological Corp.), monitored for output 
with a UVB LM H06 C meter (National Biological Corp.) The 
exposures were at a set distance (30 cm) and lasted approximately 
2-2.5 min per treatment. 
SalTlple Preparation At the appropriate times, mice were killed 
by cervical dislocation and the dorsal skin removed . For determina-
tions of ODC, SOD, CAT, and XO, the epidermis was scraped 
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Figure 1. Comparative hyperplasia in mouse skin treated with acetone, TPA, EPP, or UVR. Mice were treated with acetone, TPA,EPP, or UVR for 16 weeks 
and killed 48 h after the last treatment. The skins were processed for histology as described. Treatments are A) acetone 32X (2 times/week); B) TPA 32X 
(2/lg/trt, 2 times/week); C) EPP 32X (5 mg/trt, 2 times/week); D) UVR 48X (0.091/cm2, 3 times/week). Magnification X 750. 
from the skin with a razor blade. The scraped epidermis was homog-
enized, centrifuged, and the supernatants stored at -100°C unti l 
use. Full-thickness dorsal skin samples were analyzed for epidermal 
hyperplasia after being fixed in 10% buffered fo rmalin, embedded 
in paraffin, sectioned , and stained with hematoxylin and eosin. 
Epidermal Thickness The epidermal response to TPA, EPP, or 
UVR treatment was monitored by histologic comparison of skin 
from mice treated with acetone, 2J.Lg TPA, 5 mg EPP, or 0 .09 
J/cm2 UVR as described above. Forty-eight hours after the final 
treatment for each time point examined, the mice were ki lled and 
the dorsal skin removed and prepared for histologic examination. 
Light-microscopic examination was used to determine the degree of 
hyperplasia. Epidermal thickness was defined as the distance from 
the bottom of the basal cell layer to the top of the stratum granulo-
sum (cornified layer was excluded) and was measured using an ocu-
lar micrometer calibrated with a stage micrometer. Each epidermal 
thickness value represents the average ± SEM of20 thickness deter-
minations for skin samples from three individual mice per treat-
ment. 
Biochemical Studies The determinations of ornithine decarbox-
ylase (ODC), catalase (CAT), superoxide dismutase (SOD), and 
xanthine oxidase (XO) were performed as published previously [8). 
RESULTS 
Treatment of mouse skin with TPA, EPP, or UVR as described 
above resu lted in the rapid development of a significant epidermal 
hyperplasia. This hyperplasia resulting from all three treatments 
persisted throughout the 16-week treatment period (Fig 1). How-
ever, there were striking differences in the response curves for the 
different treatments in both the timing of the hyperplasia and even 
more so in the extent of the hyperplasia induced (Fig 2). Epidermal 
thickness in acetone-treated skin ranged from 20 ± 0.5 J.Lm to 
23 ± 1 J.Lm over the 16-week period. Hyperplasia, as evidenced by 
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Figure 2. Epidermal thickness expressed in micrometers. All means plotted 
are significantly different (p < 0.05 by Dunnett t test) from acetone-treated 
control, except TPA and EPP after 0.5 weeks, TPA after 12 weeks, and TPA 
after 16 weeks of treatments . • , acetone; ., TPA; ", EPP; a, UVR. 
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Figure 3. Epidermal ornithine decarboxylase activity expressed as times 
increase over acetone-treated control va lues (100%) .• , means significantly 
different from acetone-treated control (p < 0.05 by Dunnctts t tes t) . • , 
TPA; f§l, EPP; I, UVR. 
epidermal thickness, induced by TPA peaked at 2 weeks (49 ± 
6 p.m) and declined to near control levels by 16 weeks (27 ± 4,wn). 
EPP-induced hyperpl aS ia was maXUTIum at 12 weeks (78 ± 20 J.l.m), 
with a decrease observed at 16 weeks as compared to 12 weeks. 
UVR-induced hyperplas ia was significantly elevated after two 
treatments (47 ± 6 J.l.m versus 20 ± 0.5 J.l.m for acetone) and waS 
continuing to increase at 16 weeks (95 ± 23 J.l.m versus 20 ± 2 j.J.m 
for acetone. 
ODC activity was significantly induced by all three treatments 
(TPA> EPP > UVR). The pattern of C?DC inducti?n did not cor-
relate with the hyperplaSia observed (Fig 3). TPA-mduced ODe 
activity, although maintained at a near constant level, was at its 
maximum after 8 weeks of treatment (136X acetone value). In COn-
trast to TPA treatment, EPP and UVR inductions of ODC activity 
were greatest after a sin.gle treatment (139X and 93X acetone values, 
respectively) and steadily declll1ed to lower levels at 16 weeks (62)< 
and 13X acetone values, respectively). 
Epidermal SOD activity was decreased in all treatment groups 
comparable to acetone, for the first 4 weeks of treatment (Fig 4). At 
8 weeks of treatment, SOD levels in the epidermis of animals ex-
posed to TPA and UVR returned to control (acetcin~) levels and 
remained so throughout the remamder of the expenment. EPP-
treated epidermis contained decreased levels of SOD at 2 weeks of 
treatment and these levels remained depressed for the duration of 
the experiment. 
CAT activi ty was decreased in all treatment groups relative to 
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Figure 4. Epidermal superoxide dismutase activity expressed as percent of 
acetone-treated control values (100%) .• , mea ns significantl y different 
from acetone-trea ted control (p < 0.05 by Dunnetts t test) . • , TPA; !§j, 
EPP; I, UVR. 
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Figure 5. Epidermal catalase activity expressed as percent of acetone-
treated control values (100%). All treatment means are significantly differ-
ent from control, except those marked with an. (p < 0.05 by Dunnetts 
t test) .• , TPA; f§l, EPP; I, UVR. 
acetone, after the initial treatments (0.5 weeks) and, except for a tew 
points, remained at levels below those seen in the acetone controls 
throughout the 16-week study (Fig 5). 
XO activity (an endogenous source of superoxide) was increased 
in TPA- and EPP-treated epidermis consistently throughout the 
experiment, with a dramatic increase observed at 8 weeks for the 
EPP-treated epidermis (Fig 6) . No effect on XO activity by UVR 
was observed until the 16-week time point. 
DISCUSSION 
Acute exposure of mouse epidermis to tumor-promoting regimens 
results in the rapid development of marked hyperplasia and alter-
ations in a number of biochemical parameters of the epidermal cells. 
Among these changes are an increase in ODC activity (a marker for 
cellular proliferation) [2,3), decreases in epidermal antioxidants 
such as SOD and CAT [4,5,7,8), as well as increased oxidant produc-
tion resulting from elevated XO activity [9) . Exact data as to 
whether these changes persist during chronic promoter treatment 
are scarce. 
In order to address this question, we exposed hairless mice to 
TPA, EPP, or UVR at regular intervals for 16 weeks and monitored 
epidermal hyperplasia and ODC, SOD, CAT, and XO activity 
during this treatment period. The data indicate differences in the 
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Figure 6. Epidermal xa nthine ox idase activity expressed as percent of 
acetone- trea ted control va lues (100%) .• , means significantly different 
from acetone-treated contro l (I' < 0.05 by Dunnetts t test) .• , TPA; f§l, 
EPP; I, UVR. 
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magnitude, timing, and duration of the responses to the different 
agents. 
Hyperplasia in response to tumor-promoter exposure has been 
shown to be a necessary event for the process of tumor promotion. 
Promotion-sensitive mice, such as the SEN CAR mouse, show ex-
tensive hyperplasia in response to TP A exposure that remains at 
high levels throughout the treatment period [10], whereas promo-
tion-resistant animals (BALB/c mice and hamsters) show an initial 
TPA-induced hyperplasia that recedes following repeated TPA 
treatments [11,12] . In the present study, epidermal hyperplasia (as 
measured by epidermal thickness) increased after the initial treat-
ments and remained elevated for the duration of the experiment for 
all treatment groups. TPA-induced hyperplasia reached a peak at 2 
weeks and then slowly declined, whereas EPP- and UVR-induced 
hyperplasia continued to increase throughout the experiment. 
The time course of epidermal hyperplasia reported here agrees 
with literature data. Epidermal thickness in hairless mice treated 
repeatedly with TPA has been reported to reach approximately 
1.9X that of acetone-treated controls after 7 weeks of treatment, but 
declined to approximately 1.5X that of controls when measured 1 
week after 18 weeks of treatment [13] . Chronic exposure of mouse 
skin to EPP has been reported sparingly. Raick and Baxter report 
increased epidermal thickness following 4 weeks of EPP treatment 
[14,15]. These studies report only a single point and do not address 
the progress of the hyperplasia over extended time periods, typical 
of promotion protocols. 
Data presented here are in agreement with studies that have dem-
onstrated the induction of ODC activity by tumor-promoting doses 
ofTPA [2,3]' EPP [2,16,17], and UVR [8,18]. As has been demon-
strated with other strains of mice, TPA was generally the most 
effective at inducing ODC activity, followed by EPP, with UVR 
being the least effective. ODC induction by TPA was relatively 
constant. On the other hand, EPP- and UVR-induced ODC activ-
ity was at its greatest after the first treatment and steadily declined 
thereafter. 
Decreases in antioxidant enzyme levels following single treat-
ments with tumor promoters and UVR have been documented in 
the literature [4,7,8] . Data presented here indicate that this decrease 
persists for extended periods of time and may depend on the pro-
moter being applied and on the antioxidant being monitored. Epi-
dermal SOD activity was decreased by TPA, EPP, and UVR for 4 
weeks and then returned to normal levels in the TP A- and UVR-
exposed mice, whereas EPP treatments continued to depress SOD 
levels throughout the 16-week experiment. This would indicate 
that the type of promoter may have a significant effect on whether 
the epidermis might eventually compensate for chronic exposure to 
certain types of damage. It is possible that the TPA- and UVR-
treated skins began to produce more SOD in response to the chronic 
damage and were able to maintain normal levels even when chal-
lenged by the promoter. 
In contrast to the SOD levels, CAT levels were consistently de-
pressed by the promoter treatments throughout the study. This may 
indicate a greater free radical load for this enzyme or an inability of 
the epidermis to increase endogenous levels of CAT to a level suffi-
cient to prevent the tumor promoter-induced decrease observed. 
Epidermal XO activity (an endogenous superoxide generation 
system) is increased in the TPA- and EPP-treated mice throughout 
the experiment and may explain some of the decrease in SOD levels 
observed. These data are in good agreement with that of previous 
work with SEN CAR mice in which TPA and EPP treatment both 
resulted in significant increases in epidermal XO over as-week 
treatment period [19]. 
Taken as a whole, these data indicate that prolonged exposure of 
mouse epidermis to the tumor promoters TPA, EPP, or UVR results 
in significant hyperplasia and ODC activity, and to decreased epi-
dermal antioxidant enzyme activities. It should be noted that ODC 
inducibility is associated more with TPA treatment than with EPP 
or UVR exposure, both of wh ich result in greater hYferplastic re-
sponses than does TPA exposure, indicating a lack 0 coupling of 
ODC induction to the hyperplastic response. This continued expo-
sure of the epidermis to free radicals and the resulting decline in the 
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end(}g;enous ability of the epidermis to scavenge these compounds 
may playa major role in the induction of tumors by UVR and in the 
grovvt:h of tumors in tumor-promoting protocols. Therefore, an-
tioxidant status and its sustained compromise may be markers of the 
deVelopment of both UV-induced and chemically promoted skin 
tumors. Further research into mechanisms by which these processes 
OCCllr is underway. 
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